Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Pharmaceutical Engineering in 2026 and Its Role Across the GMP Lifecycle

From early facility decisions to requalification, small engineering gaps can become costly GMP findings. Explore how risk-based design, commissioning, equipment qualification, maintenance, and change control build inspection-ready systems—and what regulators expect to see in the supporting records.
  • Blog, Validation and Qualification
Pharmaceutical engineer using a tablet beside stainless-steel processing equipment in a GMP cleanroom, with digital equipment qualification diagrams and lifecycle monitoring graphics.

LIMS Software in Pharma in 2026: A GMP Guide to Validation and Data Integrity

Can your QC laboratory trace every result from sample registration to final approval? Learn how GMP LIMS supports data integrity, what inspectors check, and how risk-based LIMS validation helps keep pharmaceutical laboratories inspection-ready throughout the system lifecycle.
  • Blog, Computerized System Validation
Two pharmaceutical QC scientists reviewing a digital laboratory workflow with sample tracking, chromatogram results, and approval controls, illustrating GMP LIMS data integrity.

NATCO Calls 4 FDA Observations Procedural; Response Quality Now Matters Most

NATCO Pharma’s finished dosage formulations facility in Parawada, Visakhapatnam, received a U.S. FDA Form 483 with four observations after an inspection conducted from August 17 to 21, 2026. NATCO described the observations as procedural and said it expects to address
  • News
NATCO Calls 4 FDA Observations Procedural; Response Quality Now Matters Most

Gilead, Pfizer and GSK Warn on AI; Fix GMP Workflows Before Scaling

Senior quality leaders from Gilead Sciences, Pfizer and GSK used the Bioprocessing Summit in Boston to caution pharmaceutical companies against rushing weak processes into digital and AI systems. Their message was consistent: digital technology can improve quality operations, but poorly
  • News
Gilead, Pfizer and GSK Warn on AI; Fix GMP Workflows Before Scaling

FDA Warning Letter Flags OOS Averaging; Confirmed OOS Still Led to Batch Release

The U.S. Food and Drug Administration (FDA) has issued a Warning Letter to ABS Corporation, a veterinary drug manufacturer in Omaha, Nebraska, after a January 2026 inspection identified significant CGMP violations involving OOS investigations, incoming component testing, and process validation.
  • News
FDA Warning Letter Flags OOS Averaging; Confirmed OOS Still Led to Batch Release

Pharma Legislation in 2026: Drug Approval, GMP Requirements, Pharmacovigilance, and Global Compliance Guide

Explore how pharmaceutical regulations shape drug development, marketing authorization, GMP requirements, and pharmacovigilance across major markets. This guide explains global regulatory frameworks, approval pathways, compliance expectations, and inspection readiness for pharmaceutical companies operating under changing regulatory requirements.
  • Blog, Quality Management System
Global pharmaceutical regulatory framework showing GMP regulations, marketing authorization, regulatory authorities, and compliance monitoring.

Regulatory Specialist in 2026: Role, Skills, Qualifications, Salary, and Pharma Career Path

A Regulatory Specialist connects regulatory submissions, GMP compliance, change control, and inspection readiness across the pharmaceutical lifecycle. This guide explains the role, essential skills, qualifications, salary factors, and career path for professionals working in pharmaceutical regulatory affairs.
  • Blog, Quality Management System
Pharmaceutical regulatory affairs professional reviewing regulatory submissions, change control records, and inspection readiness documentation.

Pharma Trust Starts Before PR; GMP Compliance Becomes the Real Test

Pharmaceutical Executive examined how leading drugmakers build and measure trust across their organizations and found that the foundation starts before reputation, ESG, or public communication. It starts with safe, effective, high-quality medicines and genuine regulatory compliance. The analysis matters for
  • News
Pharma Trust Starts Before PR; GMP Compliance Becomes the Real Test

AI Spending Is Surging, Results Aren’t; Workforce Qualification May Explain Pharma’s ROI Gap

Pharma companies continue to increase AI investment, but expected gains in development timelines and success rates remain limited. In an August 10, 2026 analysis for Pharmaceutical Technology, Brian Drapeau argues that workforce qualification may be the missing link. The issue
  • News
AI Spending Is Surging, Results Aren’t; Workforce Qualification May Explain Pharma’s ROI Gap

ISO 9000 in Pharma Industry in 2026: QMS Principles, ISO 9001, GMP Alignment and Implementation Guide

Explore how ISO 9000 principles support pharmaceutical quality systems, strengthen GMP compliance, and connect with ISO 9001 and ICH Q10. Learn how quality teams can apply process-based management, risk-based decisions, and continual improvement to build inspection-ready operations.
  • Blog, Quality Management System
Pharmaceutical quality management system showing GMP compliance, process approach, quality controls, and continual improvement across regulated manufacturing operations.